Ticker Scorecard - THRD Basics Company: Third Harmonic Bio, Inc. IPO Date: September 15, 2022 Sector: Healthcare Industry: Biotech Market Cap: $156.35M Activated in VL: True Average Daily Range Avg Daily Range: $0.30 | 2.97% Avg Daily Range (30 D): $0.28 | 4.39% Avg Daily Range (90 D): $0.38 | 3.77% Institutional Daily Volume Avg Daily Volume: .15M Avg Daily Volume (30 D): .81M Avg Daily Volume (90 D): .37M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 183 Avg Trade Size (Sh.) (90 D): 139 Institutional Trades Total Inst.Trades: 105 Avg Inst. Trade: $2.25M Avg Inst. Trade (30 D): $1.47M Avg Inst. Trade (90 D): $2.1M Avg Inst. Trade Volume: .27M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.54M Avg Closing Trade (30 D): $2.99M Avg Closing Trade (90 D): $2.07M Avg Closing Volume: 341.84K     News Feb 12, 2025 @ 9:41 PM Third Harmonic Bio Initiates Strategic Review, Lay... Source: Vandana Singh Nov 7, 2024 @ 9:00 PM Third Harmonic Bio to Participate in Upcoming Inve... Source: N/A May 28, 2024 @ 8:05 PM Third Harmonic Bio to Participate in the Jefferies... Source: Third Harmonic Bio May 15, 2024 @ 4:12 PM Biogen (BIIB) Partner Begins Filing for Leqembi SC... Source: Zacks Equity Research May 15, 2024 @ 12:05 PM Third Harmonic Bio Announces First Quarter 2024 Fi... Source: Third Harmonic Bio Financials   TTM TTM Q3 2024 Basic EPS $.15 $.96 $.33 Diluted EPS $.15 $.96 $.33 Revenue $ 89M $ 13.65M $ 3.28M Gross Profit $ 61.89M $ $ Net Income / Loss $ 4.32M $ -39.2M $ -13.8M Operating Income / Loss $ 3.29M $ -52.84M $ -17.07M Cost of Revenue $ 27.11M $ $ Net Cash Flow $ -15.7M $ -4.81M $ M PE Ratio 23.13